Document Detail

The vascular response to photodynamic therapy with ATX-S10Na(II) in the normal rat colon.
MedLine Citation:
PMID:  15896649     Owner:  NLM     Status:  MEDLINE    
The mechanism of tissue damage from photodynamic therapy (PDT) may be cellular, vascular or both, depending on the photosensitising agent and the treatment conditions. Well established photosensitisers like porfimer sodium have an optimum drug light interval of two days and may cause skin photosensitivity lasting several weeks. ATX-S10Na(II) is a new photosensitiser that remains largely in the vasculature after systemic administration and clears from the body within a few hours. The present study looks at the factors controlling the extent of PDT necrosis using ATX-S10Na(II) and correlates these with changes in the circulation after PDT. Normal Wistar rats were sensitised with ATX-S10Na(II), 2 mg/kg. At laparotomy, a laser fibre was positioned just touching the colonic mucosa and 50 J light at 670 nm delivered varying the drug light interval (0.5-24 h) and light delivery regime (100 mW continuous, 20 mW continuous or 100 mW in five fractions). Some animals were killed at three days to document the area of necrosis, others received fluorescein shortly prior to death (from a few minutes to three days after PDT) to outline the zone of PDT induced vascular shutdown. Maximum necrosis was seen with the shortest drug light interval (0.5 h), with no effect by 6 h. Fractionating the light or lowering the power did not increase the necrosis. The area of fluorescein exclusion increased over the first 2 h after PDT (in contrast to the re-perfusion seen with other photosensitisers) and correlated with the area of necrosis. PDT with ATX-S10Na(II) is most effective with a drug light interval of less than one hour. It induces irreversible vascular shutdown that extends after completion of light delivery and which is largely independent of the light delivery regime.
Masahiko Harada; Josephine Woodhams; Alexander J MacRobert; Mark R Feneley; Harubumi Kato; Stephen G Bown
Related Documents :
25294499 - Illusory movements induced by tendon vibration in right- and left-handed people.
23226489 - Dispersal range of anopheles sinensis in yongcheng city, china by mark-release-recaptur...
6850009 - Sites of action of light during phototherapy.
25177189 - Kinematical analysis along maximal lactate steady state swimming intensity.
11259379 - Reactive oxygen-dependent production of novel photochemotherapeutic agents.
742659 - Brushing and physiological arousal.
21928969 - Current reversals in a rocking ratchet: the frequency domain.
1342839 - Inhibitory sidebands in multiple angular frequency filters in the human visual system.
21496239 - Physiological and behavioral reactions elicited by simulated and real-life visual and a...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, Non-P.H.S.    
Journal Detail:
Title:  Journal of photochemistry and photobiology. B, Biology     Volume:  79     ISSN:  1011-1344     ISO Abbreviation:  J. Photochem. Photobiol. B, Biol.     Publication Date:  2005 Jun 
Date Detail:
Created Date:  2005-05-17     Completed Date:  2006-09-12     Revised Date:  2007-07-23    
Medline Journal Info:
Nlm Unique ID:  8804966     Medline TA:  J Photochem Photobiol B     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  223-30     Citation Subset:  IM    
National Medical Laser Centre, Academic Division of Surgical Specialties, Royal Free and University College Medical School, 1st Floor, Charles Bell House, 67-73 Riding House Street, London W1W 7EJ, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Colon / blood supply*,  drug effects*,  radiation effects
Microscopy, Fluorescence
Photosensitizing Agents / pharmacology*
Porphyrins / pharmacology*
Rats, Wistar
Spectrometry, Fluorescence
Reg. No./Substance:
0/ATX S10Na(II); 0/Fluoresceins; 0/Photosensitizing Agents; 0/Porphyrins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Techniques for delivery and monitoring of TOOKAD (WST09)-mediated photodynamic therapy of the prosta...
Next Document:  Determination of the distribution of light, optical properties, drug concentration, and tissue oxyge...